Rob Johnson
Chief Executive Officer · Oyster Therapeutics · London, United Kingdom
Biotechnology · Series A · Founded 2020
Latest raise
$60M
Date raised
November 10, 2026
Round
Series A
Founded2020
InvestorsHilal Ventures, 4BIO Capital
About Rob Johnson
a pharmaceutical company developing next-generation targeted protein degraders with an initial focus on tau-driven diseases like Alzheimer’s
- Who is Rob Johnson?
- Rob Johnson is listed as Chief Executive Officer at Oyster Therapeutics, a biotechnology company founded in 2020 based in London, United Kingdom.
- How much did Oyster Therapeutics raise?
- Oyster Therapeutics raised $60M in a Series A round on November 10, 2026 (3 days ago). Backed by Hilal Ventures, 4BIO Capital.
Get newly funded founders every week
A free weekly list of startups that just raised.